Dostarlimab

TargetMol Chemicals

Dostarlimab

999

2022215-59-2

Antibody

Research Use Only

Dostarlimab

Dostarlimab (TSR-042) is a humanized monoclonal antibody targeting PD-1 with high affinity, designed to block its interaction with ligands PD-L1 and PD-L2. By competitively inhibiting these interactions, it achieves IC50 values of 1.8 nM for PD-L1 and 1.5 nM for PD-L2, demonstrating its effective inhibition capabilities [1].

3 years

-20°

12352200